Sandbox g37: Difference between revisions

Jump to navigation Jump to search
Gerald Chi- (talk | contribs)
mNo edit summary
Gerald Chi- (talk | contribs)
mNo edit summary
Line 13: Line 13:
:::* Preferred regimen: [[Ceftriaxone]] 2.0 g IV q8h {{and}} [[Clindamycin]] 600–900 mg IV q8h {{and}} [[Metronidazole]] 500 mg IV q6h
:::* Preferred regimen: [[Ceftriaxone]] 2.0 g IV q8h {{and}} [[Clindamycin]] 600–900 mg IV q8h {{and}} [[Metronidazole]] 500 mg IV q6h


:* Specific anatomic considerations
:* Specific anatomic considerations<ref>{{cite book | last = Hall | first = Jesse | title = Principles of critical care | publisher = McGraw-Hill Education | location = New York | year = 2015 | isbn = 978-0071738811 }}</ref>
::*
::*

Revision as of 06:21, 11 June 2015

  • Deep neck infection
  • Empiric antimicrobial therapy[1][2]
  • Community-acquired deep neck infection
  • Nosocomial deep neck infection or immunocompromised host
  • Deep neck infection with high-risk of MRSA
  • Necrotizing fasciitis
  • Specific anatomic considerations[3]
  1. Flint, Paul (2010). Cummings otolaryngology head & neck surgery. Philadelphia, PA: Mosby/Elsevier. ISBN 978-0323052832.
  2. Vieira, Francisco; Allen, Shawn M.; Stocks, Rose Mary S.; Thompson, Jerome W. (2008-06). "Deep neck infection". Otolaryngologic Clinics of North America. 41 (3): 459–483, vii. doi:10.1016/j.otc.2008.01.002. ISSN 0030-6665. PMID 18435993. Check date values in: |date= (help)
  3. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.